Penny stock Acurx Pharmaceuticals (NASDAQ:ACXP) is a clinical-stage biopharmaceutical company developing antibiotics for difficult-to-treat bacterial infections, with its lead candidate, ibezapolstat, being developed for Clostridioides difficile infection, a serious and often recurrent gastrointestinal infection. Shares closed at $1.40 at last closing, down 2.10%.
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) fell 0.58% to $98.92 at last closing. Zimmer Biomet is a leading medical-device company specializing in musculoskeletal healthcare, best known for its orthopedic implants for knees, hips and other joints, along with products for sports medicine, extremities, trauma, and …
Universal Health Services, Inc. (NYSE:UHS) rose 1.03% to $169.21 at last closing. Universal Health Services is one of the largest hospital and healthcare-facility operators in the United States, running acute-care hospitals and a large behavioral-health division that operates psychiatric and addiction-treatment facilities.
U.S. Physical Therapy, Inc. (NYSE:USPH) fell 0.27% to $14.98 at last closing. US Physical Therapy operates one of the largest networks of outpatient physical-therapy clinics in the United States, typically through partnerships in which it holds majority interests alongside local clinic operators.
Milestone Scientific, Inc. (NYSE American:MLSS) rose 1.08% to $0.47 at last closing, a penny-stock price. Milestone Scientific is a small medical-technology company that develops computerized drug-delivery instruments designed to make injections more precise and controlled, with products in dental anesthesia and its CompuFlo platform …
● Tenaya Therapeutics is a clinical-stage biotechnology company developing gene therapies and other treatments for genetic heart disease.
● IGC Pharma is a clinical-stage biopharmaceutical company focused on developing treatments for Alzheimer's disease and related conditions.
● Ardent Health operates a network of hospitals and other healthcare facilities across multiple regional health systems.
● ABT shares fell 1.75% to $108.54 in Thursday's intraday session, underperforming both the healthcare sector (XLV) and the broader market.
● Nature's Sunshine Products makes and sells nutritional and personal-care products through a direct-sales model and other channels.